[#item_full_content] Canadian biotech stocks are drawing fresh attention as higher interest rates stay in focus after US Federal Reserve officials kept the door open to more hikes. When money has a clearer price, balance sheet strength and valuation discipline matter more. That is exactly what this group offers. This article walks through three Canadian biotechnology picks from the screener that aim to combine scientific upside with financial resilience. The stocks highlighted below are just a starter pack, and…
Read More